Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
Annemieke de Jong, Ali Jabbari, Zhenpeng Dai, Luzhou Xing, Dustin Lee, Mei Mei Li, Madeleine Duvic, Maria Hordinsky, David A. Norris, Vera Price, Julian Mackay-Wiggan, Raphael Clynes, Angela M. Christiano
Annemieke de Jong, Ali Jabbari, Zhenpeng Dai, Luzhou Xing, Dustin Lee, Mei Mei Li, Madeleine Duvic, Maria Hordinsky, David A. Norris, Vera Price, Julian Mackay-Wiggan, Raphael Clynes, Angela M. Christiano
View: Text | PDF
Research Article Dermatology

High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata

  • Text
  • PDF
Abstract

Alopecia areata (AA) is an autoimmune disease in which cytotoxic T cells specifically target growing hair follicles. We used high-throughput TCR sequencing in the C3H/HeJ mouse model of AA and in human AA patients to gain insight into pathogenic T cell populations and their dynamics, which revealed clonal CD8+ T cell expansions in lesional skin. In the C3H/HeJ model, we observed interindividual sharing of TCRβ chain protein sequences, which strongly supports a model of antigenic drive in AA. The overlap between the lesional TCR repertoire and a population of CD8+NKG2D+ T cells in skin-draining lymph nodes identified this subset as pathogenic effectors. In AA patients, treatment with the oral JAK inhibitor tofacitinib resulted in a decrease in clonally expanded CD8+ T cells in the scalp but also revealed that many expanded lesional T cell clones do not completely disappear from either skin or blood during treatment with tofacitinib, which may explain in part the relapse of disease after stopping treatment.

Authors

Annemieke de Jong, Ali Jabbari, Zhenpeng Dai, Luzhou Xing, Dustin Lee, Mei Mei Li, Madeleine Duvic, Maria Hordinsky, David A. Norris, Vera Price, Julian Mackay-Wiggan, Raphael Clynes, Angela M. Christiano

×

Figure 2

The majority of expanded T cell clones in recipient lesions are newly primed T cells.

Options: View larger image (or click on image) Download as PowerPoint
The majority of expanded T cell clones in recipient lesions are newly pr...
Skin from a donor with spontaneous AA (donor 1) was grafted onto 5 recipient mice, which subsequently developed AA. The TCRβ repertoire of donor skin and new lesions in recipients was sequenced and plotted as a 3D histogram of variable versus joining region genes versus number of reads (counts) (A). The percentages of all detected TCRβ sequences in donor and recipient skin samples were plotted, showing sequences shared between donor and recipient (percentage shared [blue]), sequences unique to donor (percentage on y axis [green]), and sequences unique to recipient (percentage on x axis [red]). The most expanded clones from the donor skin are detected at lower frequencies in recipient lesions (top left quadrant), and the most expanded clones in the recipient lesions are primarily unique to the recipient (bottom right quadrant, red circle) (B). The percentage of donor sequences present in new recipient lesions is indicated (Overlap).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts